Below are stories that I have written recently on cancer and hematology. The links below should work for anyone with a login for Medscape or MD Edge. If you don’t have a login and would like to read any of these stories, tweet at me at @kdooleyyoung and I may be able to send you a PDF of the story. A major focus in oncology at this time is the FDA’s use of accelerated approvals.
Routine Breast Cancer Screening Should Start at Age 40: USPSTF, April 30, 2024. Medscape.
Panel: MRD Tests May Speed Myeloma Tx Approvals, April 15, 2024. MDEdge Hematology.
FDA’s Cancer-Drug Rebuff Hints at Stricter Stance, March 27, 2024. MDedge Hematology News
Myeloma: FDA Advisers Greenlight Early CAR-T, March 18, 2024. MDEdge Hematology News.
Top US Oncology Regulator Seeks Changes in Drug Studies, Feb. 2, 2024, MDEdge Hematology News.
Grail Gets FDA OK for Study of Cancer Blood Test, Nov. 27, 2023. Medscape Medical News.
FDA Panel Voices Concerns Over Two Lymphoma Accelerated Approvals, Nov. 17, 2023. Medscape Medical News
Are AI-Powered Skin-Check Tools on the Horizon for Dermatologists, PCPs?, Aug. 1, 2023. Medscape Medical News.
US Mammogram Update Sparks Concern, Reignites Debates, July 18, 2023. Medscape Medical News.
Take 2: CMS Launches Successor to the Oncology Care Model, June 30, 2023. Medscape Medical News.
Proposal to Cap Part B Pay on Some Drugs Draws Opposition, June 20, 2023. Medscape Medical News.
New USPSTF Draft Suggests Mammography Start at 40, Not 50, May 9, 2023. Medscape Medical News.
Panel Backs Limited New Olaparib Use in Prostate Cancer, May 1, 2023. Medscape Medical News.
CRC Blood Tests: A Future Without Screening Colonoscopies?, April 5, 2023. Medscape Medical News.
Lawmakers and Patients Seek to Reduce Enzalutamide Cost, Feb. 24, 2023. Medscape Medical News.
Approvals and Withdrawals: Inside the Cancer Drug Terrain of 2022, Jan. 23, 2023. Medscape Medical News.
Law Gives Some Relief on Cancer Drug Costs, but More Help Needed, Dec. 12. Medscape Medical News.
FDA Panel Votes Against Omburtamab for Rare Pediatric Cancer, Nov. 1, 2022. Medscape Medical News.
FDA Panel Finds Duvelisib Risks Outweigh Benefits in CLL/SLL, Sept. 26, 2022. Medscape Medical News.
Follow-up Trial of Myeloma Drug ‘Flopped,’ Says FDA Panel, Sept. 23, 2022. Medscape Medical News.
FDA Panel Rebuffs Poziotinib for NSCLC in 9-4 Vote, Sept. 23, 2022. Medscape Medical News.
Problems With Drugs That Get Speedy OKs: What To Do? Aug. 25, 2022. Medscape Medical News.
Devices to Detect Skin Cancer: FDA Advisers Offer Mixed Views, Aug. 1, 2022. Medscape Medical News.
FDA Panel Urges Caution With Skin-Cancer-Detecting Tools, July 29, 2022. Medscape Medical News.
Exercise and Ovarian Cancer: How Moving Can Help You, July 25, 2022. WebMD.
FDA Panel: Concerns Over PI3K Inhibitors in Blood Cancers, April 22, 2022. Medscape Medical News.
Lawmaker Seeks Deadlines on FDA Accelerated Drug Approvals, March 18, 2022. Medscape Medical News.
FDA Panel Rejects Sintilimab Clinical Trial Data From China, Feb. 11, 2022. Medscape Medical News.
Cancer Hospitals Fail to Reveal Prices: ‘It’s Not Always Shopable’, Dec. 2, 2021. Medscape Medical News.
Paying Less for Drugs With Problematic Approvals, Sept. 29, 2021. Medscape Medical News.
FDA Targets Cancer Indications That Fail to Prove Clinical Benefit, March 17, 2021. Medscape Medical News.
Medicaid to Cover Routine Costs for Patients in Trials, Dec. 30, 2020. Medscape Medical News.
Judge Delays Rule That Cuts Pay for Drugs in Docs’ Offices, Dec. 28, 2020. Medscape Medical News.
Medicare Will Test Pay Models for Radiation Oncology, Dialysis, Sept. 18, 2020. Medscape Medical News.
Blood test detects colon cancer in single-center study, May 13, 2020. Internal Medicine News/MDEdge.
Medicare to Cover Gene Tests in Inherited Breast and Ovarian Cancer, Jan. 29, 2020. Medscape Medical News.
Cirrhosis Patients Skimp on Cancer Screening Because of Cost, Nov. 13, 2019. Medscape Medical News.
Patient-reported outcomes are here to stay, Sept. 27, 2019. MDEdge’s Hematology & Oncology.
CMS weighs extension of Oncology Care Model, Sept. 27, 2019. MDEdge’s Hematology & Oncology.
Medicare Announces Coverage for CAR T-Cell Therapy, Aug. 8, 2019. Medscape Medical News.
Threat to Cancer Care From State Policies, July 2, 2019. Medscape Medical News.
Physicians Less Likely to Order Cancer Screening Late in Day, May 24, 2019. Medscape Medical News.
FDA Allows Continued Sales of Textured Breast Implants, May 3, 2019. Medscape Medical News.
More Info on Risks of Breast Implants Needed, Says FDA Panel, March 27, 2019. Medscape Medical News.
Head of National Cancer Institute to Serve as Interim FDA Chief, March 13, 2019. Medscape Medical News.
Medicare Moves Closer to CAR-T Coverage Policy, Feb. 18, 2019. Medscape Medical News.
Immunotherapy Combos: Will Cost Put Them out of Reach?, Oct. 15, 2018. Medscape Medical News. Immunotherapy has already revolutionized cancer care. Combining various immunotherapies promises even greater success, but will the already high cost of these therapies put combos out of reach?
Researchers seek more sickle cell drug research, Nov. 8, 2018. Hematology News.
Antigen profiling may help prevent transfusion complications, Nov. 8, 2018. Hematology News.
Primary care needs pile up for sickle cell patients, Nov. 1, 2018. Hematology News.
Sickle cell disease gene therapy seen advancing, Oct. 31, 2018. Hematology News.
How to Increase Access Cancer Drugs Discussed at NCCN Meeting, Sept. 25, 2018. Medscape Medical News.
CMS Advisers Back Patient Reporting Tools for CAR-T Drugs, Aug. 23, 2018. Medscape Medical News. A panel of experts voted in support of four tools for collecting patient-reported outcomes that Medicare could factor into payment decisions for costly CAR-T cancer drugs.
Cancer Groups Object to Medicare Proposals to Cut Part B, July 19, 2018. Medscape Medical News.
Helping Cancer Patients to Understand New ‘Right-to-Try’ Law, June 13, 2018, Medscape Medical News. PDF version.
Congress Passes Right-to-Try Bill, May 22, 2018. Medscape Medical News.
CMS Publicizes Costliest Increases for Medicare, Medicaid Drugs, May 17, 2018. Medscape Medical News.
Senate HELP Panel Explores More Clarity for 340B Drug Program, May 16, 2018. Medscape Medical News.
FDA Chief Highlights Cost as Obstacle to Cancer Treatment , Medscape Medical News, April 12, 2018.